Table 3. Summary measures of clinical outcome along with 95 % confidence intervals.

Variable	No/mild leukoaraiosis (n = 28)	Moderate/severe leukoaraiosis
		(n = 28)	+ clinically silent chronic lacunar infarcts (n = 21)
Favorable outcome: 6 months, n (%, 95 % CI)	22 (79, 63–94)	16 (57, 38–76)	12 (57, 35–79)
Favorable outcome: 12 months, n (%, 95 % CI)	22 (79, 63–94)	19 (67, 50–86)	14 (67, 45–88)
mRS: d/c, median (range)	1 (0–5)	2 (0–4)	2 (0–4)
mRS: 6 months, median (range)	0.5 (0–5)	1 (0–6)*	1 (0–6)*
mRS: 12 months, median (range)	1 (0–5)	1 (0–6)	1 (0–6)
Ischemic event: 6 months, n (%)	0	1 (4)	1 (5)
Ischemic event: 12 months, n (%)	0	2 (7)	2 (10)
Death: 12 months, n (%)	0	1 (4)	1 (5)

Comparisons were made between no/mild and moderate/severe leukoaraiosis groups mRS modified Rankin scale, d/c discharge

^*Indicates p value <0.05